High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma
Trial ID or NCT#
To evaluate the role of allogeneic hematopoietic cell transplantation in the treatment of NHL.
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma
- Morphologically confirmed relapsed non-Hodgkin's lymphoma Age: >18 and <61 years of age Signed informed consent
- Hepatic dysfunction defined by serum transaminases >2.5X normal values Serum creatinine of > 2 mg/dl or creatinine clearance < 60 ml/min Diseases other than non-Hodgkin's lymphoma Prior bone marrow transplant procedure Severe psychological or medical illness
Contact us to find out if this trial is right for you.